1041 | Well ye | Mary Johnson | 10/18/2012 10:55:00 AM |
1040 | I think | theellasmith | 10/18/2012 10:53:24 AM |
1039 | Green reminder | Mary Johnson | 10/18/2012 10:51:42 AM |
1038 | You are | Mary Johnson | 10/18/2012 10:45:36 AM |
1037 | Do you | theellasmith | 10/18/2012 10:45:00 AM |
1036 | I agree | aleksdavis | 10/18/2012 10:42:22 AM |
1035 | The | Mary Johnson | 10/18/2012 10:41:32 AM |
1034 | AGIJ - load up! | theellasmith | 10/18/2012 10:38:45 AM |
1033 | Imo we | Mary Johnson | 10/18/2012 10:37:34 AM |
1032 | Exactly | aleksdavis | 10/18/2012 10:37:26 AM |
1031 | AGIJ - resistance is close | theellasmith | 10/18/2012 10:34:42 AM |
1030 | Third t | aleksdavis | 10/18/2012 10:31:12 AM |
1029 | AGIJ - be informed | theellasmith | 10/18/2012 10:28:28 AM |
1028 | Mens skin care growthNPD Study Shows Potential | mwirmm | 10/18/2012 7:53:59 AM |
1027 | Thanks | mwirmm | 10/18/2012 7:50:56 AM |
1026 | Thats t | mwirmm | 10/18/2012 7:43:05 AM |
1025 | Well hi | mwirmm | 10/18/2012 7:40:17 AM |
1024 | Crossing my fingers for that | Milly Joel | 10/18/2012 7:37:18 AM |
1023 | Good sh | mwirmm | 10/18/2012 6:54:18 AM |
1022 | Well it | mwirmm | 10/18/2012 6:53:05 AM |
1021 | AGIJ Chart | John Howard | 10/18/2012 6:49:41 AM |
1020 | Nice catch, I've been analyzing AGIJ's chart | John Howard | 10/18/2012 6:38:55 AM |
1019 | People | John Howard | 10/18/2012 6:35:07 AM |
1018 | that'r | John Howard | 10/18/2012 6:32:08 AM |
1017 | Maybe new investors are unaware of the AGIJ's | Milly Joel | 10/18/2012 6:30:15 AM |
1016 | I think | John Howard | 10/18/2012 6:29:42 AM |
1015 | Definit | John Howard | 10/18/2012 6:27:07 AM |
1014 | Yearly overview Last year in the very same | Milly Joel | 10/18/2012 6:24:55 AM |
1013 | Patience pay off For a month AGIJ's PPS is | Milly Joel | 10/18/2012 6:17:32 AM |
1012 | Ready for the breakthrough Current price is | Milly Joel | 10/18/2012 6:12:34 AM |
1011 | Experts Opinion Short term indicator is green, we | Milly Joel | 10/18/2012 6:10:46 AM |
1010 | I am de | Mary Johnson | 10/17/2012 1:57:43 PM |
1009 | Well I | Mary Johnson | 10/17/2012 1:54:20 PM |
1008 | What do | theellasmith | 10/17/2012 1:52:27 PM |
1007 | You are | Mary Johnson | 10/17/2012 1:51:49 PM |
1006 | Conside | theellasmith | 10/17/2012 1:50:06 PM |
1005 | The ent | theellasmith | 10/17/2012 1:46:56 PM |
1004 | AGIJ - incoming? | theellasmith | 10/17/2012 1:45:08 PM |
1003 | I think | Mary Johnson | 10/17/2012 1:45:02 PM |
1002 | AGIJ - don't miss it | theellasmith | 10/17/2012 1:41:32 PM |
1001 | Short run | Mary Johnson | 10/17/2012 1:33:32 PM |
1000 | They wi | aleksdavis | 10/17/2012 11:19:58 AM |
999 | Can you | aleksdavis | 10/17/2012 11:15:13 AM |
998 | I think | aleksdavis | 10/17/2012 11:07:59 AM |
997 | Looks g | aleksdavis | 10/17/2012 11:02:14 AM |
996 | 7 Day A | aleksdavis | 10/17/2012 10:51:56 AM |
995 | I think | mwirmm | 10/17/2012 10:10:15 AM |
994 | Somethi | mwirmm | 10/17/2012 10:10:01 AM |
993 | Opinion | mwirmm | 10/17/2012 10:09:36 AM |
992 | Going s | mwirmm | 10/17/2012 10:08:59 AM |
Recent Articles
- Exploring E&R's Cutting-Edge Technologies at SEMICON Taiwan
- Mesoblast's Milestones: FDA Approval and Strategic Growth
- Highlights of Mesoblast's Record Year: FDA Approval and Growth
- Replimune Group Inc. Class Action Update for Shareholders
- Faruqi & Faruqi Investigates Replimune Group for Shareholders
- Frontier Lithium Releases Financial Milestones and Updates
- Expansion in Water Sector: Scruggs and NTS Join Forces
- Gamehaus Holdings Inc. Launches Strategic Share Buyback Plan
- Bogotá's Strategic Mission to Enhance Investment with Japan
- Exciting Developments at Picard Medical with $17 Million IPO
- Eagle Pharmaceuticals Welcomes Abhinav Jain to Its Board
- Stetson University Celebrated for Distinction in Education
- Sable Offshore Investors Rally: Legal Actions Begin
- Transform Your Investment Strategy with US Foods Holdings Today
- Investors Alert: LifeMD Inc Faces Legal Investigation Risks
- Everest Medicines Reports Strong Interim Growth in 2025
- Simply Solventless Sees Exceptional Growth with $13 Million in Revenue
- Everest Medicines Reports Strong Financial Growth for H1 2025
- Exploring Adobe's Stock Growth Track Record Over Two Decades
- Faruqi & Faruqi Investigates Flywire Corporation's Claims
- Investigation into Petco's Shareholder Claims and Stock Trends
- Eagle Pharmaceuticals Welcomes Abhinav Jain to Board of Directors
- Investigating Legal Claims for RxSight Investors with RXST
- Revolutionizing Recycling: Veolia Partners with EverestLabs
- Strong Financial Performance Report from Central 1 Credit Union
- Investors Urged to Evaluate Their Rights with Altimmune, Inc.
- Understanding Your Rights as an Encompass Health Investor
- Faruqi & Faruqi Investigates Centene Investor Claims
- Investigation into Lockheed Martin Sparks Investor Interest
- The Remarkable Growth of Intuitive Surgical Investments
- Investigation Launched for iRobot Corporation Investors
- Investigation Update: Biohaven Ltd and Shareholder Rights
- Profiting from KLA Stock Over Two Decades: A Closer Look
- Investors Alert: Capricor Therapeutics Faces Legal Investigation
- Investigation Unfolds for Fiserv Investors Amid Allegations
- Understanding Cohen & Steers Quality Income Realty Fund Updates
- Understanding the Sources of Distributions for RFI Investors
- Cohen & Steers REIT and Preferred Income Fund (RNP) Update
- Cohen & Steers Infrastructure Fund Announces Distribution Details
- RedPeak Appoints Josh Foley as CEO to Lead New Era
- What If You Invested $100 in AutoZone Over a Decade Ago?
- Exciting Developments in Marvell Technology's Q2 Earnings Results
- Josh Foley Takes the Helm at RedPeak as New CEO
- Teamsters California's Initiative for Workers' Rights and AI
- Discover How Guitar Crafting Hinges on Elephant Conservation
- TCCOH Takes Action Following Data Security Incident Notification
- LifeMD Investors Pursue Class Action Amid Legal Review
- Cohen & Steers Closed-End Opportunity Fund Distribution Update
- Atlas Energy Reports Strong Q2 2025 Financial Growth Results
- Understanding Distributions from Cohen & Steers Opportunity Fund